"A MUTLI-CENTRE, DOUBLE-BLIND, RANDOMISED, PLACEBO-CONTROLLED PARALLEL-GROUP STUDY TO ASSESS THE TOLERABILITY OF TOLERMUNE HOUSE DUST MITE IN SUBJECTS WITH CONTROLLED ASTHMA AND HOUSE DUST MITE-INDUCED RHINOCONJUNCTIVITIS."

Registry ID
TH004
Source registry
HEALTH_CANADA
Status
Pending
Study type
INTERVENTIONAL
Sponsor
CIRCASSIA LTD
Start date
2013-10-09
Last update
2013-09-19

Conditions

Related clinical trials

View on source registry